Brian G Atwood's Net Worth

$797 Million

Estimate Recalculated Feb 21, 2024 06:00PM EST

Who is Brian G Atwood?

Brian G Atwood has an estimated net worth of $797 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., INSULET CORP, PHASERX, INC., Trius Therapeutics Inc, PHARMION CORP, XENOGEN CORP, GLAUKOS Corp, VERACYTE, INC., PHOENIX BIOTECH ACQUISITION CORP., Clovis Oncology, Inc., OPGEN INC, Inogen Inc, Atreca, Inc., SECOND SIGHT MEDICAL PRODUCTS INC, Locust Walk Acquisition Corp., NOVACEA INC, GENOMIC HEALTH INC, CADENCE PHARMACEUTICALS INC, FIVE PRIME THERAPEUTICS INC, INTRALASE CORP, Alexza Pharmaceuticals Inc., HELICOS BIOSCIENCES CORP, and Flexion Therapeutics Inc.

SEC CIK

Brian G Atwood's CIK is 0001266567

Past Insider Trading and Trends

2014 was Brian G Atwood's most active year for acquiring shares with 80 total transactions. Brian G Atwood's most active month to acquire stocks was the month of October. 2004 was Brian G Atwood's most active year for disposing of shares, totalling 152 transactions. Brian G Atwood's most active month to dispose stocks was the month of April. 2016 saw Brian G Atwood paying a total of $15,999,990.00 for 2,119,372 shares, this is the most they've acquired in one year. In 2014 Brian G Atwood cashed out on 5,669,788 shares for a total of $3,755,196.45, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 4
Form 4
0
0
Jan 7
Form 4
2.21M
$12.00
-$2,500,008.00
2.21M
Jul 29
Form 3
0
0
No matching records found

INSULET CORP (PODD) Snapshot price: $199.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.13M
2.13M
May 14
Form 3
0
0
No matching records found

PHASERX, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 25
Form 4
0
0
Jun 1
Form 4
+21.36%
341.96K
$2.51
$2,997,419.56
1.94M
May 23
Form 4
+21.36%
341.96K
$2.51
$2,997,419.56
1.94M
May 23
Form 3/A
0
0
Form 3/A
0
0
Form 3
0
0
Form 3
0
0
No matching records found

Trius Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Sep 11
Form 4
0
0
May 21
Form 4
0
0
May 22
Form 4
0
0
Jun 2
Form 4
0
0
Nov 3
Form 4
3.24M
$4.72
3.24M
Aug 6
Form 3
0
0
Form 3
0
0
No matching records found

No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-15.20K
0
Mar 7
Form 4
0
0
Jun 6
Form 4
0
0
Jun 8
Form 4
0
0
Jun 1
Form 4
-96.82%
-462.48K
15.2K
Feb 23
Form 4
-49.17%
-461.91K
477.5K
Oct 27
Form 4
0
0
Jun 2
Form 4
-0.30%
-2.80K
$37.34
-$104,544.00
939.4K
May 25
Form 4
-6.08%
-63.10K
$36.05
-$2,274,717.00
975.09K
May 25
Form 4
-3.50%
-34.10K
$36.95
-$1,259,947.00
940.99K
May 25
Form 4
-0.24%
-2.50K
$38.67
-$96,670.00
1.04M
May 24
Form 4
-2.86%
-97.50K
$38.05
-$3,725,114.00
3.31M
May 24
Form 4
-2.75%
-64.49K
$39.51
-$2,596,121.00
2.28M
May 21
Form 4
-34.52%
-634.54K
$38.72
-$3,264,214.00
1.2M
May 21
Form 3
0
0
No matching records found